Quantcast

Latest Treatment for depression Stories

2008-10-30 09:00:41

SAN DIEGO, Oct. 30 /PRNewswire/ -- An expected 2,500 mental health professionals will convene at the San Diego Convention Center today for the 2008 U.S. Psychiatric and Mental Health Congress amid a deepening economic crisis causing new waves of anxiety disorders to ripple through American society. The 21st annual Congress runs through Sunday. More than 100 sessions and symposia are scheduled throughout the four-day Congress, all of which will provide practice-related, clinically relevant...

2008-10-13 03:00:17

By Cole, David Depression is more common among women than men, and researchers - including here - are studying the differences between the sexes, such as hormonal fluctuations and biochemical factors, for possible answers to why that's the case. Janice M. Kusch, a Washington State University psychology professor and director of the school's psychology clinic in Pullman, says women in North America are two to three times more likely than men to experience depression during their lifetime....

2008-10-09 09:00:10

SAINT LAURENT, QUEBEC and GREAT FALLS, VIRGINIA--(Marketwire - Oct. 9, 2008) - IntelGenx Corp. (TSX:IGX)(OTCBB:IGXT) ("IntelGenx") and Cary Pharmaceuticals Inc. ("Cary Pharma") today announced positive results from a clinical trial on its antidepressant CPI 300. The results from the bioequivalence study undertaken in September 2008 confirm that CPI 300 is bioequivalent to the reference product. IntelGenx and Cary Pharma will be filing a New Drug Application ("NDA") (505(b)(2) based on the...

2008-10-08 09:00:12

MALVERN, Pa., Oct. 8 /PRNewswire/ -- Neuronetics, Inc., a privately-held medical device company and a leader in the field of neuromodulation, announced today that the U.S. Food and Drug Administration (FDA) has cleared its NeuroStar TMS (Transcranial Magnetic Stimulation) Therapy system for the treatment of depression. NeuroStar TMS Therapy(R) is specifically indicated for the treatment of Major Depressive Disorder in adult patients who have failed to achieve satisfactory improvement from...

2008-10-04 00:00:07

Getting help for depression and anxiety has significant long-term benefits, a University of Alberta researcher said. Study leader Ian Colman said most people are not getting the type of treatment they need. The team studied a group of 200 people who were diagnosed with either depression or anxiety, and of this group, 45 were on medication. The group of 200 had their mental health assessed in 1989 through a series of questions on a survey asking about their illness and what, if any,...

2008-09-11 09:00:48

US-based biopharmaceutical company Rexahn Pharmaceuticals has received the FDA approval to begin Phase II trials for Serdaxin, for the treatment of major depressive disorders. The Serdaxin Phase II trial is a randomized, double-blind, placebo-controlled parallel study for the treatment of major depressive disorders. It is a multi-center trial with preliminary data in humans expected in the second half of 2009. According to the company, Serdaxin is being developed as an orally...

2008-09-10 09:00:09

Rexahn Pharmaceuticals, Inc. (AMEX: RNN), a leader in innovative therapeutics for life-threatening and life-debilitating diseases, announced today that the Company has received FDA approval to begin Phase II trials for Serdaxin(TM), for the treatment of major depressive disorders (MDD). This trial represents the third Phase II study currently in progress at Rexahn Pharmaceuticals. The Company's leading cancer compound, Archexin(TM), and its drug for treating erectile dysfunction,...

2008-08-30 09:00:21

By Samuels, Noah Gropp, Cornelius; Singer, Shepherd Roee; Oberbaum, Menachem The use of complementary and alternative medicine (CAM) is on the rise, especially among psychiatric patients. Acupuncture is considered a safe and effective treatment modality, and traditional Chinese medicine teaches that acupuncture harmonizes the body's energies. Scientific research has found that acupuncture increases a number of central nervous system hormones (ACTH, beta-endorphins, serotonin, and...

2008-07-28 06:01:22

Numerous studies have shown the benefits of omega-3 fatty acids for everything from decreasing joint pain to improving cardiovascular and ophthalmologic health. Depression is another condition garnering attention from researchers studying the benefits of omega-3s. Wellness Professionals(TM), the leader in arthritis pain relief, is pleased to announce that their omega-3 supplement, Ximega(TM), will be used in a clinical trial at Memorial Sloan Kettering Cancer Center as a treatment for...

2008-07-22 09:00:21

RESEARCH TRIANGLE PARK, N.C., July 22 /PRNewswire/ -- CeNeRx BioPharma, Inc., a clinical stage company developing and commercializing innovative treatments for diseases of the central nervous system, today announced plans to advance its lead candidate Tyrima(TM) into Phase II trials for the treatment of depression and anxiety. This milestone is based on the positive results of the Tyrima Phase I program reported earlier this year and the recent completion of PET brain imaging studies showing...


Word of the Day
conjunto
  • A style of popular dance music originating along the border between Texas and Mexico, characterized by the use of accordion, drums, and 12-string bass guitar and traditionally based on polka, waltz, and bolero rhythms.
The word 'conjunto' comes through Spanish, from Latin coniūnctus, past participle of coniungere, to join together; see conjoin